Affymetrix Announces Q4 2013 Revenue of Approximately $91M, FY 2013 Revenue of Approximately $329M
Affymetrix (NASDAQ: AFFX) today announced that based on
preliminary, unaudited financial data, the Company expects total revenue
for the fourth quarter of 2013 will be approximately $91 million,
including a one-time licensing payment of $5.3 million from a diagnostic
partner. For fiscal 2013, the Company expects total revenue of
approximately $329 million.